Skip to content

Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes

Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00885430
Enrollment
20
Registered
2009-04-22
Start date
2008-07-31
Completion date
2008-09-30
Last updated
2015-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamics, Hyponatremia

Keywords

colonoscopy, preparation

Brief summary

Twenty adult volunteers will be administered Pico-Salax in the usual fashion for colonoscopy with intense monitoring of serum and urine chemistry and hemodynamics.

Interventions

Two sachets of Pico-Salax given 5 hours apart

Sponsors

Ferring Pharmaceuticals
CollaboratorINDUSTRY
Queen's University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* healthy volunteers older than 45

Exclusion criteria

* impaired renal function * congestive heart failure ascites known electrolyte abnormalities

Design outcomes

Primary

MeasureTime frame
serum electrolytes48 hours
patient hemodynamics48 hours

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026